Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,003 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05560009 | An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas | completed | — | 9 | Mayo ClinicOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT02320292 | Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma | terminated | Phase 3 | 20 | Mayo ClinicOTHER | 1 | Jul 9, 2025 |
| clinicaltrials |
| NCT01628640 | Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors | completed | Phase 1 | 17 | Mayo ClinicOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT03106415 | Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer | completed | Phase 1 / Phase 2 | 23 | Mayo ClinicOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT03713294 | Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma | completed | Phase 2 | 37 | Mayo ClinicOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT05388851 | Education for Prevention of Melanoma in Hispanic Populations | terminated | Phase 2 | 145 | Mayo ClinicOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT06151717 | A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma | completed | — | 50 | Mayo ClinicOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT05447910 | Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer | terminated | — | 21 | Mayo ClinicOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT03325101 | Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma | terminated | Phase 1 / Phase 2 | 7 | Mayo ClinicOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT02957149 | Platelet Rich Plasma During Radical Prostatectomy | completed | N/A | 24 | Mayo ClinicOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT02792322 | Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck | completed | N/A | 32 | Mayo ClinicOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT03012880 | Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma | completed | Phase 2 | 80 | Mayo ClinicOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06494046 | Defining Musical Toxicity and Its Effect on Patient Well-being | withdrawn | — | 0 | Mayo ClinicOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06284447 | Barriers to Cervical Cancer Screening | completed | — | 2,216 | Mayo ClinicOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT04129411 | Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation | completed | N/A | 5 | Mayo ClinicOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT04892264 | Belantamab Mafodotin, Lenalidomide, and Daratumumab for the Treatment of Relapsed, Refractory, or Previously Untreated Multiple Myeloma | terminated | Phase 1 | 5 | Mayo ClinicOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT03456700 | Auranofin and Sirolimus in Treating Participants With Ovarian Cancer | terminated | Phase 2 | 22 | Mayo ClinicOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT04839679 | A Study to Evaluate Visually Inspired Patient Education Material on Willingness to Pursue Radiation Therapy | terminated | N/A | 51 | Mayo ClinicOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT05053100 | Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study | completed | — | 100 | Mayo ClinicOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT06011824 | A Study of Effect of Megakaryocytes and Platelets in Breast Cancer | completed | — | 23 | Mayo ClinicOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT06834386 | Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients | withdrawn | Phase 4 | 0 | Mayo ClinicOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT03736564 | Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia | completed | Phase 1 / Phase 2 | 18 | Mayo ClinicOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT05878405 | Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer | completed | Phase 3 | 49 | Mayo ClinicOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT02598726 | Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer | completed | Phase 1 | 9 | Mayo ClinicOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06915103 | A Case Report of NMDAR Encephalopathy | completed | — | 1 | Mayo ClinicOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT03768349 | PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer | completed | Early Phase 1 | 250 | Mayo ClinicOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06182332 | An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care | completed | N/A | 221 | Mayo ClinicOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT04917744 | Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors | completed | — | 5 | Mayo ClinicOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT04742231 | Handheld Dynamometer During Awake Craniotomy Pilot | completed | N/A | 10 | Mayo ClinicOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT01767636 | Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 38 | Mayo ClinicOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT05113199 | Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer | completed | N/A | 21 | Mayo ClinicOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT04213794 | Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients(TOASTIT) | terminated | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT05523154 | "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures | terminated | N/A | 8 | Mayo ClinicOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT02921893 | Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome | completed | Early Phase 1 | 21 | Mayo ClinicOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT02908477 | Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer | completed | Phase 3 | 228 | Mayo ClinicOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT05407038 | Remote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related Fatigue | terminated | N/A | 7 | Mayo ClinicOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06112795 | Exploring Cultural Acceptability of Community Breast Cancer Risk Assessment Among Hispanic Women in Maricopa County | completed | — | 25 | Mayo ClinicOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT04294225 | Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer | completed | Phase 2 | 161 | Mayo ClinicOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT02020720 | 18F-DOPA-PET in Planning Surgery in Patients With Gliomas | completed | Early Phase 1 | 72 | Mayo ClinicOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT02766933 | Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study | completed | — | 207 | Mayo ClinicOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT02648763 | Staging Procedures to Diagnose Malignant Pleural Mesothelioma | terminated | — | 33 | Mayo ClinicOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT00670358 | Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma | completed | Phase 1 / Phase 2 | 138 | Mayo ClinicOTHER | 1 | Jan 10, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials